Savara
SVRA
#5447
Rank
A$1.97 B
Marketcap
A$9.70
Share price
-0.31%
Change (1 day)
75.41%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.15 Billion a decrease over its 2023 earnings that were of -A$82.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion25.05%
2024 -A$0.15 Billion75.29%
2023 -A$82.26 Million43.38%
2022 -A$57.37 Million-11.31%
2021 -A$64.69 Million-13.3%
2020 -A$74.61 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$0.11 Billion105.54%
2017 -A$50.28 Million34.11%
2016 -A$37.49 Million-37.43%
2015 -A$59.92 Million38.81%
2014 -A$43.17 Million33.62%
2013 -A$32.31 Million38.49%
2012 -A$23.33 Million24.59%
2011 -A$18.73 Million-36.5%
2010 -A$29.49 Million-3.14%
2009 -A$30.44 Million-23.28%
2008 -A$39.68 Million8.52%
2007 -A$36.56 Million-34.14%
2006 -A$55.52 Million184.43%
2005 -A$19.52 Million90.75%
2004 -A$10.24 Million190.35%
2003 -A$3.53 Million11.64%
2002 -A$3.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.31 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA